EPISODE · Sep 13, 2024 · 21 MIN
Carle Health Chooses Nabla for Its Workflow Focus
from Healthcare IT Today Interviews · host John Lynn
The term "workflow" comes up repeatedly in this interview with Dr. Ed Lee, Chief Medical Officer at Nabla, and Dr. David Lovinger, MD, FHM, FACP, Associate Chief Medical Officer and Chief Informatics Officer one of Nabla's clients, Carle Health of central Illinois. Lee said that it's critical for AI Medical Scribe solutions to fit in with clinicians' workflows. Lovinger advises clinicians to understand their site's workflows very well when choosing a solution. Carle Health chose Nabla after testing many ambient voice products; Lovinger says they are "not all created equal." Carle Health found reaction from its clinicians to be "uniformly positive" after a four-week pilot. Learn more about Nabla: https://www.nabla.com/ Learn more about Carle Health: https://carle.org/ AI Medical Scribe Solutions: https://www.healthcareittoday.com/ambient-clinical-voice-companies/
What this episode covers
The term "workflow" comes up repeatedly in this interview with Dr. Ed Lee, Chief Medical Officer at Nabla, and Dr. David Lovinger, MD, FHM, FACP, Associate Chief Medical Officer and Chief Informatics Officer one of Nabla's clients, Carle Health of central Illinois. Lee said that it's critical for AI Medical Scribe solutions to fit in with clinicians' workflows. Lovinger advises clinicians to understand their site's workflows very well when choosing a solution. Carle Health chose Nabla after testing many ambient voice products; Lovinger says they are "not all created equal." Carle Health found reaction from its clinicians to be "uniformly positive" after a four-week pilot. Learn more about Nabla: https://www.nabla.com/ Learn more about Carle Health: https://carle.org/ AI Medical Scribe Solutions: https://www.healthcareittoday.com/ambient-clinical-voice-companies/
NOW PLAYING
Carle Health Chooses Nabla for Its Workflow Focus
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Feb 4, 2026 ·18m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m